NCT03781505

Brief Summary

To investigate whether the addition of intravenous paracetamol with caudal ropivacaine leads to better quality of postoperative recovery in patients undergoing hypospadius repair than caudal ropivacaine alone. The quality of recovery will be judged by postoperative analgesia requirement and lesser agitation in the postoperative period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Jan 2019

Typical duration for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 23, 2018

Completed
27 days until next milestone

First Posted

Study publicly available on registry

December 20, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

January 31, 2019

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2022

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2022

Completed
2.3 years until next milestone

Results Posted

Study results publicly available

August 16, 2024

Completed
Last Updated

August 16, 2024

Status Verified

March 1, 2024

Enrollment Period

3.2 years

First QC Date

November 23, 2018

Results QC Date

August 4, 2023

Last Update Submit

March 15, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Postoperative Analgesia Requirement

    The requirement of postoperative analgesia of the patient will be evaluated by using Children's Hospital of Eastern Ontario Pain Scale (CHEOPS). This scale has 5 domains. It includes crying, facial expression, verbal response, touching the wound and torso and leg movement. It is a behavioural scale and measures each domain on a numerical scale of 0 to 2. Minimum score is 0 while maximum score is 10. Aggregate score will be added. Score less than 4 will be consider adequate analgesia while score greater than 4 will be consider inadequate analgesia. CHEOPS Pain Score less than four in participants of C and P groups will be reported at different time points.

    follow till 6 hours postoperatively

Secondary Outcomes (1)

  • Sedation

    follow till 4 hours postoperatively

Study Arms (2)

Intravenous paracetamol with Caudal Ropivacaine

EXPERIMENTAL

Paracetamol is widely accepted and most commonly used as an adjuvant for postoperative analgesia. It also improves the quality of recovery by attenuating the pain associated with the surgical position. Adverse effects associated with the paracetamol are rare \<1/10000, which includes malaise, increased level of hepatic transaminases and hypersensitivity reaction. It has been studied in combination with caudal analgesia with bupivacaine through the rectal route 7,8 with variable results. Caudal anaesthesia is effective in alleviating pain below the umbilicus. Also if the caudal block is administered at the beginning of surgery, the effect will start wearing off 2 to 3 hours post surgery. Administration of paracetamol towards end of surgery may help with both these issues. In this study we aim to investigate the effect of adding intravenous paracetamol in combination with caudal analgesia with ropivacaine, hoping that it may improve quality of postoperative analgesia and recovery.

Drug: Paracetamol +caudal ropivacaine

Placebo

PLACEBO COMPARATOR

Intravenous Normal Saline with Caudal Ropivacaine

Drug: Placebo

Interventions

Paracetamol + Ropivacaine

Intravenous paracetamol with Caudal Ropivacaine

Caudal ropivacaine

Placebo

Eligibility Criteria

Age3 Years - 10 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age 3-10 years
  • ASA (American Society of Anesthesiologists) I and II
  • Undergoing hypospadias repair surgery

You may not qualify if:

  • Coagulopathy
  • Aspirin or any other analgesic ingestion in the preceding week
  • Preexisting neurological or spinal disease
  • Hepatic, renal disease and malnutrition
  • Severe hypovolemia
  • Uncontrolled convulsions
  • Refusal of the parents
  • Local Skin infection at the puncture site
  • Allergy to local anesthetics
  • Patient previously involved in other studies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aga Khan University Hospital

Karachi, Sindh, 74800, Pakistan

Location

Related Publications (10)

  • Hosseini Jahromi SA, Sadeghi Poor S, Hosseini Valami SM, Javadi A. Effects of suppository acetaminophen, bupivacaine wound infiltration, and caudal block with bupivacaine on postoperative pain in pediatric inguinal herniorrhaphy. Anesth Pain Med. 2012 Spring;1(4):243-7. doi: 10.5812/aapm.3551. Epub 2012 Apr 1.

    PMID: 24904808BACKGROUND
  • Samuel M, Hampson-Evans D, Cunnington P. Prospective to a randomized double-blind controlled trial to assess efficacy of double caudal analgesia in hypospadias repair. J Pediatr Surg. 2002 Feb;37(2):168-74. doi: 10.1053/jpsu.2002.30247.

    PMID: 11819193BACKGROUND
  • Mercan A, Sayin MM, Saydam S, Ozmert S, Tiryaki T. When to add supplemental rectal paracetamol for postoperative analgesia with caudal bupivacaine in children? A prospective, double-blind, randomized study. Paediatr Anaesth. 2007 Jun;17(6):547-51. doi: 10.1111/j.1460-9592.2006.02141.x.

    PMID: 17498016BACKGROUND
  • Ozyuvaci E, Altan A, Yucel M, Yenmez K. Evaluation of adding preoperative or postoperative rectal paracetamol to caudal bupivacaine for postoperative analgesia in children. Paediatr Anaesth. 2004 Aug;14(8):661-5. doi: 10.1111/j.1460-9592.2004.01255.x.

    PMID: 15283825BACKGROUND
  • Ozbek H, Bilen A, Ozcengiz D, Gunes Y, Ozalevli M, Akman H. The comparison of caudal ketamine, alfentanil and ketamine plus alfentanil administration for postoperative analgesia in children. Paediatr Anaesth. 2002 Sep;12(7):610-6. doi: 10.1046/j.1460-9592.2002.00913.x.

    PMID: 12358657BACKGROUND
  • Gunter JB. Benefit and risks of local anesthetics in infants and children. Paediatr Drugs. 2002;4(10):649-72. doi: 10.2165/00128072-200204100-00003.

    PMID: 12269841BACKGROUND
  • Mohammed BS, Engelhardt T, Cameron GA, Cameron L, Hawksworth GM, Hawwa AF, McElnay J, Helms PJ, McLay JS. Population pharmacokinetics of single-dose intravenous paracetamol in children. Br J Anaesth. 2012 May;108(5):823-9. doi: 10.1093/bja/aes025. Epub 2012 Mar 1.

    PMID: 22389380BACKGROUND
  • Perrott DA, Piira T, Goodenough B, Champion GD. Efficacy and safety of acetaminophen vs ibuprofen for treating children's pain or fever: a meta-analysis. Arch Pediatr Adolesc Med. 2004 Jun;158(6):521-6. doi: 10.1001/archpedi.158.6.521.

    PMID: 15184213BACKGROUND
  • Prins SA, Van Dijk M, Van Leeuwen P, Searle S, Anderson BJ, Tibboel D, Mathot RA. Pharmacokinetics and analgesic effects of intravenous propacetamol vs rectal paracetamol in children after major craniofacial surgery. Paediatr Anaesth. 2008 Jul;18(7):582-92. doi: 10.1111/j.1460-9592.2008.02619.x. Epub 2008 May 8.

    PMID: 18482233BACKGROUND
  • Nnaji CT, Onajin-Obembe B, Ebirim L. The analgesic effects of rectal diclofenac versus rectal paracetamol following caudal-bupivacaine for pediatric day-case inguinal herniotomies: a randomized controlled prospective trial. J Pediatr Surg. 2017 Sep;52(9):1384-1388. doi: 10.1016/j.jpedsurg.2017.05.001. Epub 2017 May 5.

    PMID: 28535959BACKGROUND

Results Point of Contact

Title
Dr. Muhammad Saad Yousuf
Organization
Aga Khan University

Study Officials

  • Muhammad S Yousuf, FCPS

    Aga Khan University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized control trail
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 23, 2018

First Posted

December 20, 2018

Study Start

January 31, 2019

Primary Completion

April 30, 2022

Study Completion

May 1, 2022

Last Updated

August 16, 2024

Results First Posted

August 16, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations